Stocks were indicated to open higher on Monday morning on positive trade talks and international market strength. The Dow Jones industrial average was set to open up 0.5% or so and near 27,400 that would get it to an all-time after the S&P 500 hit all-time highs last seek. It is increasingly evident that those imminent recession calls by the media have been proven very wrong. Still, investors have a lot of negative issues and other types of changes to consider at a time when the current bull market is well over 10 years old. Investors should be considering what changes they should make in their portfolios and assets heading into late 2019 and as 2020 approaches.
24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for traders and long-term investors alike. Some of the daily analyst calls cover stocks to buy, while some calls cover stocks to sell or to avoid.
We have provided these calls in a quick-hit summary for easy reading, and additional comments and trading data have been added on some of the calls. The consensus analyst price targets and other valuation metrics are from the Refinitiv sell-side research service.
These are the top analyst upgrades, downgrades and initiations for Monday, November 4, 2019.
Alibaba Group Holding Ltd. (NYSE: BABA) was down 0.15 at $176.46 on Friday and was indicated up 2.2% at $180.40 on Monday. JPMorgan reiterated it as Overweight and raised its target price to $235 from $230.
Alteryx Inc. (NYSE: AYX) was named as the Bull of the Day at Zacks, which said that the favorite big-data analytics engine of the Global 2000 just delivered 65% sales growth into a $24 billion total addressable market. The shares most recently closed at $99.28, with a consensus price target of $129.33.
Arista Networks Inc. (NYSE: ANET) was maintained as Neutral and the target price was slashed to $200 from $285 (versus a $185.30 prior close, after a 24% drop) at UBS.
AT&T Inc. (NYSE: T) was reiterated as Buy and the price target was raised to $42 from $38 at UBS.
Bank of America Corp. (NYSE: BAC) was reiterated as Overweight and its target price was raised to $33 from $30 (versus a $31.80 close) at JPMorgan. The prior consensus target price was $33.40, and the 52-week trading range is $22.66 to $32.23.
BioNTech S.E. (NASDAQ: BNTX) was started as Buy with a $21 price objective at Merrill Lynch. UBS started it as Buy with a $21 target, Berenberg started it as Buy with a $25 target, and JPMorgan started it as Overweight with a $23 target price.
BlackBerry Ltd. (NYSE: BB) was raised to Neutral from Underperform at Merrill Lynch.
Boeing Co. (NYSE: BA) was maintained as Equal Weight and the target price was lowered to $353 from $367 (versus a $345.19 close) at Barclays.
Citigroup Inc. (NYSE: C) was reiterated as Overweight and its target price was raised to $84.50 from $77.50 (versus a $73.84 close, after a 3.5% gain) at JPMorgan. Citi had a prior consensus target price of $83.10 and a 52-week trading range of $48.42 to $74.28.
CloudFlare Inc. (NYSE: NET) was started with an Overweight rating and a $20 target price (versus a $16.83 close) at Piper Jaffray.
DocuSign Inc. (NASDAQ: DOCU) was started as Outperform with an $80 target price (versus a $66.88 close) at Evercore ISI.
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) was raised to Neutral from Underperform at Merrill Lynch.